尿道尿酸分泌与CKD患者结局之间的关联
Yuta Asahina1, Yusuke Sakaguchi2, Tatsufumi Oka1
1Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Scientific reports
|March 1, 2024
概括
尿酸的较低分数分泌 (FEUA) 和尿尿酸与肌素的比率 (UUCR) 表明尿酸再吸收增加,这与较高的功能衰竭风险有关. 这表明抑制尿酸再吸收可能对脏健康没有好处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 代谢疾病 代谢疾病
背景情况:
- 抑制管状尿酸再吸收可以保护脏免受尿酸损伤,但可能会增加尿酸结晶的风险.
- 了解管状尿酸处理对脏结果的影响对于患者管理至关重要.
研究的目的:
- 调查管状尿酸处理之间的关联,以尿酸的分数分泌 (FEUA) 和尿尿尿酸与肌素的比率 (UUCR) 衡量,以及脏结果.
- 为了确定改变尿酸再吸收是否影响慢性病患者的功能衰竭风险.
主要方法:
- 在1042名患者的回顾性队列研究中,估计的淋巴细胞过率 (eGFR) 介于15-60毫升/分钟/1.73米2.
- 评估的暴露:尿酸的分量分泌 (FEUA) 和尿尿酸与肌素的比率 (UUCR).
- 结局定义为EGFR减半或启动替代疗法,使用多变量Cox模型进行分析.
主要成果:
- 较低的FEUA和UUCR显著与结局风险增加有关.
- 最低的FEUA四分位数显示,与最高四分位数 (P=0.01) 相比,结局的发生率高出1.68倍.
- 患有最高FEUA和UUCR的患者患有结局的风险最低,即使在酸性尿的情况下也是如此.
结论:
- 降低管状尿酸再吸收 (以较低的FEUA和UUCR表示) 与较高的功能衰竭风险有关.
- 增加尿酸的再吸收似乎有助于在受研究的人群中预防功能衰竭.
- 这些发现挑战了抑制尿酸再吸收以保护脏的策略.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
167
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
167
Renal Drug Excretion: Tubular Reabsorption
171
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
171
Renal Drug Excretion: Tubular Secretion
182
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
182
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
129
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
129
One-Compartment Open Model: Urinary Excretion Data and Determination of k
174
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
174


